Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19
Clinical trial NCT04655586 · COMPLETED
Trial details
- NCT number
- NCT04655586
- Sponsor
- ARCA Biopharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-10
- Primary completion
- 2021-12-06
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.